Do Financial Conflicts of Interest Bias Research?

  title={Do Financial Conflicts of Interest Bias Research?},
  author={Sheldon Krimsky},
  journal={Science, Technology, \& Human Values},
  pages={566 - 587}
  • S. Krimsky
  • Published 1 July 2013
  • Psychology
  • Science, Technology, & Human Values
In the mid-1980s, social scientists compared outcome measures of related drug studies, some funded by private companies and others by nonprofit organizations or government agencies. The concept of a “funding effect” was coined when it was discovered that study outcomes could be statistically correlated with funding sources, largely in drug safety and efficacy studies. Also identified in tobacco research and chemical toxicity studies, the “funding effect” is often attributed, implicitly or… 

Taking Financial Relationships into Account When Assessing Research

It is argued that it is often difficult to detect significant influences of financial relationships that affect research credibility, and at least five factors can be examined to determine whether financial relationships are likely to enhance, undermine, or have no impact on the credibility of research.

Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?

Examples of ethically performed industry-funded research and a set of principles and benchmarks for ethically credible academic–industry partnerships that could allow academic researchers, for-profit companies, and the public to benefit are provided.

Under the Influence: The Interplay among Industry, Publishing, and Drug Regulation

A critique of published and unpublished trials submitted to the Food and Drug Administration and the European Medicines Agency for approval of a new antidepressant, vortioxetine, is presented, showing how weak regulatory policies allow for design choices and reporting strategies that can make marginal products look novel, more effective, and safer than they are.

Does the type of funding influence research results – and do researchers influence funders?

Does a shift from hard to soft funding have an impact on research outcomes? Existing literature suggests that moving from hard money, such as lump-sum government-funded research, to commissioned

How can governance change research content? Linking science policy studies to the sociology of science

  • J. Gläser
  • Business
    Handbook on Science and Public Policy
  • 2019
Although science studies routinely assume that governance can change research content, we know little about how it does that. Science policy actors, commercial interests and civil society actors

Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies

In an environment where both technological and economic pressures require smarter, less-resource intense ways of understanding the value of all existing treatments, CER has tremendous potential to improve decision making through its evidence-based approach to treatment choices.

Expanding Conflicts of Interest in Public Health Research

Photo by Mehdi Imani on Unsplash ABSTRACT Non-Profit and Non-Governmental Organizations (NPOs/NGOs) often receive research funds from private for-profit corporations through Corporate Social

Governing Science

Abstract This review explores contributions by science policy studies and the sociology of science to our understanding of the impact of governance on research content. Contributions are subsumed



Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Findings indicate that pharmaceutical company sponsorship of economic analyses is associated with reduced likelihood of reporting unfavorable results.

The association between funding by commercial interests and study outcome in randomized controlled drug trials.

An association was found between the source of study support and the published outcome of randomized controlled drug trials in general interest medical journals.

Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research are reviewed to show a statistically significant association between industry sponsorship and pro-industry conclusions.

The uncertainty principle and industry-sponsored research

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Conclusions in trials funded by for-profit organizations may be more positive due to biased interpretation of trial results, and readers should carefully evaluate whether conclusions in randomized trials are supported by data.

Funding source, trial outcome and reporting quality: are they related? Results of a pilot study

It is not known whether the absence of significant associations between funding source, trial outcome and reporting quality reflects a true absence of an association or is an artefact of inadequate statistical power, reliance on voluntary disclosure of funding information, a focus on trials recently published in the top medical journals, or some combination thereof.

Conflict of interest and cost-effectiveness analysis.

Without an empirically established connection between conflict of interest and scientific outcome, many scientists and journal editors who favor financial disclosure are inclined to view it as sound public relations or as a gesture of moral correctness.

Nonfinancial conflicts of interest in research.

  • N. Levinsky
  • Education
    The New England journal of medicine
  • 2002
How nonfinancial interests of investigators can be at odds with the interests of research subjects is explored and an approach to better management of nonfinancial conflicts of interest is outlined.

Relationship between conflicts of interest and research results

COI is widespread among the authors of published manuscripts and these authors are more likely to present positive findings, and a strong association between positive results and COI (ICMJE definition) is observed.

Modeling in pharmacoeconomic studies: Funding sources and outcomes

The review of the flourishing literature based on Markov models found a substantial share of studies supported by the pharmaceutical industry, almost all concluding in favor of the drug studied, without any unfavorable conclusions at all.